公开(公告)号：US10308615B2

公开(公告)日：2019-06-04

申请号：US15574625

申请日：2016-05-16

Applicant: Pfizer Inc.

Inventor： Agustin Casimiro-Garcia ,  Jeffrey Scott Condon ,  Andrew Christopher Flick ,  Ariamala Gopalsamy ,  Steven J. Kirincich ,  John Paul Mathias ,  Joseph Walter Strobach ,  Jason Shaoyun Xiang ,  Li Huang Xing ,  Xiaolun Wang

IPC: C07D239/42 ,  C07D401/12 ,  C07D403/12 ,  A61K31/505 ,  C07D239/28 ,  C07D241/14 ,  A61P1/00 ,  A61P1/04 ,  A61P35/00 ,  C07D405/10

Abstract: Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

公开(公告)号：US20180148420A1

公开(公告)日：2018-05-31

申请号：US15574625

申请日：2016-05-16

Applicant: Pfizer Inc.

Inventor： Agustin Casimiro-Garcia ,  Jeffrey Scott Condon ,  Andrew Christopher Flick ,  Ariamala Gopalsamy ,  Steven J. Kirincich ,  John Paul Mathias ,  Joseph Walter Strobach ,  Jason Shaoyun Xiang ,  Li Huang Xing ,  Xiaolun Wang

IPC: C07D239/42 ,  A61P1/00 ,  A61P1/04 ,  A61P35/00 ,  C07D401/12 ,  C07D403/12 ,  C07D405/10

CPC classification number: C07D239/42 ,  A61K31/505 ,  A61P1/00 ,  A61P1/04 ,  A61P35/00 ,  C07D239/28 ,  C07D241/14 ,  C07D401/12 ,  C07D403/12 ,  C07D405/10

Abstract: Compounds, pharmaceutically acceptable salts thereof are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.